122 related articles for article (PubMed ID: 20944801)
1. Reflexive ordering of percent free PSA in patients: Do we need to ask the question?
Lattouf JB
Can Urol Assoc J; 2010 Oct; 4(5):321. PubMed ID: 20944801
[No Abstract] [Full Text] [Related]
2. Does the reflexive measurement of free PSA have a role in a tertiary cancer centre?
Allard C; Yip P; Blasutig I; Hersey K; Fleshner N
Can Urol Assoc J; 2010 Oct; 4(5):317-20. PubMed ID: 20944800
[TBL] [Abstract][Full Text] [Related]
3. Can percent free prostate-specific antigen reduce the need for prostate biopsy?
Lieberman S
Eff Clin Pract; 1999; 2(6):266-71. PubMed ID: 10788024
[TBL] [Abstract][Full Text] [Related]
4. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases.
Carlson GD; Calvanese CB; Partin AW
Urology; 1998 Sep; 52(3):455-61. PubMed ID: 9730460
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
[TBL] [Abstract][Full Text] [Related]
6. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
Akduman B; Alkibay T; Tuncel A; Bozkirli I
Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
[TBL] [Abstract][Full Text] [Related]
7. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist.
Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J
Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027
[TBL] [Abstract][Full Text] [Related]
8. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
Gann PH; Ma J; Catalona WJ; Stampfer MJ
J Urol; 2002 Jun; 167(6):2427-34. PubMed ID: 11992051
[TBL] [Abstract][Full Text] [Related]
9. Percent free prostate-specific antigen after radiotherapy for prostate cancer.
Crook JM; Bunting PS
Urology; 1998 Jul; 52(1):100-5. PubMed ID: 9671878
[TBL] [Abstract][Full Text] [Related]
10. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
[TBL] [Abstract][Full Text] [Related]
11. [Effect of antibiotic treatment on PSA and percentage of free PSA in patients with biochemical criteria of prostatic biopsy].
Lorente Garín JA; Arango Toro O; Bielsa Gali O; Cortadellas Angel R; Gelabert-Mas A
Actas Urol Esp; 2001 Oct; 25(9):637-44. PubMed ID: 11765547
[TBL] [Abstract][Full Text] [Related]
12. Use of percent free prostate-specific antigen density to improve the specificity for detecting prostate cancer in patients with normal rectal examinations and intermediate prostate-specific antigen levels.
Baltaci S; Aksoy H; Türkölmez K; Elhan AH; Ozden E; Göğüş O
Urol Int; 2003; 70(1):36-41. PubMed ID: 12566813
[TBL] [Abstract][Full Text] [Related]
13. Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy.
Wojno KJ; Vashi AR; Schellhammer PF; Wright GL; Montie JE
Urology; 1998 Sep; 52(3):474-8. PubMed ID: 9730464
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.
Horninger W; Volgger H; Rogatsch H; Strohmeyer D; Steiner H; Hobisch A; Klocker H; Bartsch G
J Urol; 2001 Apr; 165(4):1143-5. PubMed ID: 11257656
[TBL] [Abstract][Full Text] [Related]
15. Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions.
Gion M; Mione R; Barioli P; Barichello M; Zattoni F; Prayer-Galetti T; Plebani M; Aimo G; Terrone C; Manferrari F; Madeddu G; Caberlotto L; Fandella A; Pianon C; Vianello L
Clin Chem; 1998 Dec; 44(12):2462-70. PubMed ID: 9836713
[TBL] [Abstract][Full Text] [Related]
16. Optimum PSA reflex-range.
Benecchi L
Arch Ital Urol Androl; 2006 Jun; 78(2):44-8. PubMed ID: 16929601
[TBL] [Abstract][Full Text] [Related]
17. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
18. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Huland E; Scardino PT; Kattan MW; Huland H
J Urol; 2002 Mar; 167(3):1306-9. PubMed ID: 11832719
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario.
Gion M; Mione R; Barioli P; Barichello M; Zattoni F; Prayer-Galetti T; Plebani M; Aimo G; Terrone C; Manferrari F; Madeddu G; Caberlotto L; Fandella A; Pianon C; Vianello L; Amoroso B
Eur Urol; 2000 Apr; 37(4):460-9. PubMed ID: 10765078
[TBL] [Abstract][Full Text] [Related]
20. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
